U.S. Markets closed

Evotec AG (EVT.DE)


XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
12.47+0.02 (+0.12%)
At close: 5:35PM CEST
Interactive chart
Previous Close12.45
Open12.45
Bid0.00 x 105300
Ask0.00 x 169300
Day's Range12.36 - 12.55
52 Week Range3.10 - 13.47
Volume541,792
Avg. Volume1,266,406
Market Cap1.8B
Beta0.11
PE Ratio (TTM)49.29
EPS (TTM)0.25
Earnings DateAug 10, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Forge Therapeutics Attracts Biotechnology Leaders To Join Expanded Board Of Directors
    PR Newswire11 days ago

    Forge Therapeutics Attracts Biotechnology Leaders To Join Expanded Board Of Directors

    Following the Company's recently announced $8.8M CARB-X research award as well as the $15M Series A financing, Forge's Board now includes Mario Polywka, COO of Evotec AG, John Schmid, former CFO of Trius (acquired by Cubist Pharmaceuticals for $707M) and Auspex Pharmaceuticals (acquired by Teva for $3.5B), Stephen Worland, President and CEO of eFFECTOR Therapeutics and former CEO of Anadys Pharmaceuticals (acquired by Roche for $230M), Brian T. Dorsey, Partner of MagnaSci Ventures, and Zachary Zimmerman, CEO of Forge.  In addition, Jonathan Kabakoff of Alexandria Venture Investments and Jeffrey Moore of MP Healthcare Venture Management will serve as Board observers.

  • Forge Therapeutics Raises $15M Series A Financing to Develop First Novel Gram-Negative Antibiotic in Decades
    PR Newswirelast month

    Forge Therapeutics Raises $15M Series A Financing to Develop First Novel Gram-Negative Antibiotic in Decades

    SAN DIEGO, April 25, 2017 /PRNewswire/ -- Forge Therapeutics, Inc., (Forge), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, announced today the completion of a $15M Series A financing. The round is led by MagnaSci Ventures, with participation from Evotec AG, Alexandria Venture Investments, MP Healthcare Venture Management, Red Apple Group, and WS Investments.

  • Evotec AG breached its 50 day moving average in a Bullish Manner : EVT-DE : March 6, 2017
    Capital Cube3 months ago

    Evotec AG breached its 50 day moving average in a Bullish Manner : EVT-DE : March 6, 2017

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Evotec AG. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)